Farmington, CONNECTICUT3 Active Studies

Sickle Cell Disease Clinical Trials in Farmington, CONNECTICUT

Find 3 actively recruiting sickle cell disease clinical trials in Farmington, CONNECTICUT. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
411
Enrolling

Recruiting Sickle Cell Disease Studies in Farmington

About Sickle Cell Disease Clinical Trials in Farmington

Sickle cell disease is a group of inherited blood disorders where abnormal hemoglobin causes red blood cells to become rigid and sickle-shaped. It causes pain crises, organ damage, and shortened life expectancy. Treatment includes hydroxyurea, blood transfusions, and gene therapy.

There are currently 3 sickle cell disease clinical trials recruiting participants in Farmington, CONNECTICUT. These studies are seeking a combined 411 participants. Research is being sponsored by Novo Nordisk A/S, Agios Pharmaceuticals, Inc., Afimmune. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sickle Cell Disease Clinical Trials in Farmington — FAQ

Are there sickle cell disease clinical trials in Farmington?

Yes, there are 3 sickle cell disease clinical trials currently recruiting in Farmington, CONNECTICUT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Farmington?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Farmington research site will contact you about next steps.

Are clinical trials in Farmington free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Farmington studies also compensate for your time and travel.

What sickle cell disease treatments are being tested?

The 3 active trials in Farmington are testing new therapies including novel drugs, biologics, and treatment approaches for sickle cell disease.

Data updated March 2, 2026 from ClinicalTrials.gov